BioGaia Reports Strong Increase in Sales
Operating profit was SEK 56.3 million (47.7), an improvement of SEK 8.6 million (18%). Excluding foreign exchange effects, operating profit rose by 51%1).
2/11/2011 --- BioGaia has reported that net sales reached SEK 236.0 million (203.5), an increase of SEK 32.5 million (16%). Excluding foreign exchange effects, the increase in net sales was 27%.
Operating profit was SEK 56.3 million (47.7), an improvement of SEK 8.6 million (18%). Excluding foreign exchange effects, operating profit rose by 51%1).
Profit before tax was SEK 69.7 million (53.1), an increase of SEK 16.6 million (31%).
The year's profit after tax was SEK 47.2 million (36.0), an improvement of SEK 11.2 million (31%).
Earnings per share amounted to SEK 2.74 (2.11).
The year's cash flow from operating activities before changes in working capital was SEK 66.0 million (52.6). Total cash flow for the year was SEK 47.5 million (42.5). Dividends of SEK 25.8 million (6.9) were paid during the year at the same time that the company raised SEK 4.9 million from the new shares issued in connection with the redemption of warrants. Cash and cash equivalents at 31 December 2010 amounted to SEK 146.9 million (100.3). At the beginning of 2011 corporate tax of SEK 18.4 million attributable to 2010 was paid.
The Board proposes that the upcoming AGM approve an ordinary dividend of SEK 0.92 and an extraordinary dividend of SEK 1.08, for a total dividend of SEK 2.00 per share.
Q4 net sales amounted to SEK 62.8 million (52.3), an increase of SEK 10.5 million (20%). Excluding foreign exchange effects, the increase in net sales was 34%.1)
Operating profit was SEK 16.2 million (11.4), an improvement of SEK 4.8 million (42%). Excluding foreign exchange effects, operating profit rose by 88%. 1)
Profit before tax was SEK 18.6 million (10.5), an increase of SEK 8.1 million (77%).
Profit after tax for the period was SEK 12.9 million (6.8), an improvement of SEK 6.1 million (90%).
